Filing Flows › Zai Lab (ZLAB) › VYVGART / VYVGART Hytrulo revenue
Zai Lab (ZLAB) VYVGART / VYVGART Hytrulo revenue by quarter
Zai Lab's VYVGART / VYVGART Hytrulo revenue was $24.1M in Q3 2026 (third quarter 2026), +0.9% from Q2 2026. Over the last 6 quarters it ranged from $17.6M (Q1 2026) to $27.7M (Q3 2025).
| Quarter | VYVGART / VYVGART Hytrulo revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $24.1M | +0.9% | -13% |
| Q2 2026 | $23.9M | +36% | -10% |
| Q1 2026 | $17.6M | -20% | — |
| Q4 2025 | $21.9M | -21% | — |
| Q3 2025 | $27.7M | +5% | — |
| Q2 2025 | $26.5M | — | — |
Q3 2026 at a glance
Zai Lab, Q3 2026: revenue $108M (-7% year over year), operating margin -58.2%, net loss $46.1M, operating cash flow −$57.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Zai Lab's VYVGART / VYVGART Hytrulo revenue?
Zai Lab's VYVGART / VYVGART Hytrulo revenue was $24.1M in Q3 2026 (third quarter 2026), +0.9% from Q2 2026.
How has Zai Lab's VYVGART / VYVGART Hytrulo revenue changed?
Over the last 6 quarters it ranged from $17.6M (Q1 2026) to $27.7M (Q3 2025).